M3, Inc. (MTHRF)
15.25
0.00 (0.00%)
USD |
OTCM |
Dec 12, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 10.33B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 59.06% |
| Valuation | |
| PE Ratio | 33.70 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.668 |
| Price to Book Value | 3.940 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.1403 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.084 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 91.66% |
Profile
| M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, Overseas, and Other Emerging Businesses. The Medical Platform segment handles domestic marketing-related services that uses the Internet. It also operates the medical professional site, m3.com. The Evidence Solution segment offers business support for clinical trials. It also manages overall clinical trial operations. The Career Solution segment deals with human resources service business for medical professionals in Japan. The Site Solutions segment covers medical institution management support and home-visit nursing businesses. The Overseas segment provides services such as marketing support, research, clinical trial support, and human resources services for medical companies that use medical professional sites in the United States, United Kingdom, China, South Korea, India, France, Germany, and Spain. The Other Emerging Businesses segment includes consumer services, and medical and welfare national examination preparation services. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan. |
| URL | https://corporate.m3.com |
| Investor Relations URL | https://corporate.m3.com/en/ir/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Health Care Technology |
| Next Earnings Release | Feb. 16, 2026 (est.) |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 31, 2025 |
Ratings
Profile
| M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, Overseas, and Other Emerging Businesses. The Medical Platform segment handles domestic marketing-related services that uses the Internet. It also operates the medical professional site, m3.com. The Evidence Solution segment offers business support for clinical trials. It also manages overall clinical trial operations. The Career Solution segment deals with human resources service business for medical professionals in Japan. The Site Solutions segment covers medical institution management support and home-visit nursing businesses. The Overseas segment provides services such as marketing support, research, clinical trial support, and human resources services for medical companies that use medical professional sites in the United States, United Kingdom, China, South Korea, India, France, Germany, and Spain. The Other Emerging Businesses segment includes consumer services, and medical and welfare national examination preparation services. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan. |
| URL | https://corporate.m3.com |
| Investor Relations URL | https://corporate.m3.com/en/ir/ |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Health Care Technology |
| Next Earnings Release | Feb. 16, 2026 (est.) |
| Last Earnings Release | Nov. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 31, 2025 |